It’s becoming a familiar refrain whenever MRI developer Fonar reports financial results: sales are up, but the revenue is coming from growth in healthcare services, not scanner sales. Last month was no exception, with the Melville, NY, company
Its becoming a familiar refrain whenever MRI developer Fonar reports financial results: sales are up, but the revenue is coming from growth in healthcare services, not scanner sales. Last month was no exception, with the Melville, NY, company reporting a 34% increase in second-quarter revenues at the same time that its scanner business remained in the doldrums.
For the period (end-December), Fonar reported sales of $9.1 million, compared with revenues of $6.8 million in the same period of 1998. The companys net loss for the quarter was $2.5 million, compared with a net loss of $2.1 million in the second quarter of fiscal 1998.
Health Management Corporation of America, Fonars physician practice management subsidiary, was the engine behind the companys revenue growth. Meanwhile, sales of Fonars Quad products amounted to only $602,000 for the quarter, compared with $1 million in the same period a year ago. Fonar believes that its new scanners, such as Open Sky MRI and Stand-Up MRI, will lead to sales growth when they begin shipping.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.